ChemicalBook > CAS DataBase List > Lamotrigine

Lamotrigine

Product Name
Lamotrigine
CAS No.
84057-84-1
Chemical Name
Lamotrigine
Synonyms
LAMICTAL;LAMOTRIGIN;3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE;6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE;LTG;BW-430;BW-430C;GI 267119X;LAMOTRIGINE;Lemotrigine
CBNumber
CB4166704
Molecular Formula
C9H7Cl2N5
Formula Weight
256.09
MOL File
84057-84-1.mol
More
Less

Lamotrigine Property

Melting point:
177-181°C
Boiling point:
503.1±60.0 °C(Predicted)
Density 
1.572±0.06 g/cm3(Predicted)
Flash point:
9℃
storage temp. 
2-8°C
solubility 
DMSO: 20 mg/mL at 60 °C, soluble
pka
5.7(at 25℃)
form 
powder
color 
white
Merck 
14,5353
BCS Class
2
InChI
InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChIKey
PYZRQGJRPPTADH-UHFFFAOYSA-N
SMILES
N1C(C2=CC=CC(Cl)=C2Cl)=C(N)N=C(N)N=1
CAS DataBase Reference
84057-84-1(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
T,Xi,F
Risk Statements 
25-36/37/38-39/23/24/25-23/24/25-11
Safety Statements 
45-36-26-36/37-16
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
RTECS 
XY5850700
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
29336990
Hazardous Substances Data
84057-84-1(Hazardous Substances Data)
Toxicity
LD50 in mice, rats (mg/kg): 250, >640 orally (Sawyer)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H301Toxic if swalloed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P405Store locked up.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
L-019
Product name
Lamotrigine solution
Purity
1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
Packaging
1mL
Price
$131
Updated
2024/03/01
Sigma-Aldrich
Product number
1356756
Product name
Lamotrigine
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
150mg
Price
$816
Updated
2024/03/01
Sigma-Aldrich
Product number
BP1097
Product name
Lamotrigine
Purity
British Pharmacopoeia (BP) Reference Standard
Packaging
200MG
Price
$221
Updated
2023/06/20
TCI Chemical
Product number
L0241
Product name
Lamotrigine
Purity
>98.0%(HPLC)(T)
Packaging
1g
Price
$76
Updated
2024/03/01
TCI Chemical
Product number
L0241
Product name
Lamotrigine
Purity
>98.0%(HPLC)(T)
Packaging
5g
Price
$261
Updated
2024/03/01
More
Less

Lamotrigine Chemical Properties,Usage,Production

Description

Lamotrigine, also known by the brand name Lamictal®, is a second-generation antiepileptic drug (AED) manufactured by GlaxoSmithKline in the UK and USA. Lamotrigine is a new mazine, glutamate inhibitor anticonvulsant that significantly reduces the incidence of refractory partial seizures. The drug is reported to produce fewer CNS side effects than diazepam or sodium phenytoin. It is also indicated as add-on therapy for the treatment of generalized seizures not satisfactorily controlled by other anti-epileptics.

Chemical Properties

It is a white to cream coloured powder that is soluble in isopropanol and somewhat soluble in water. It has a melting point of 216-218°C and readily dissolves in organic solvents like benzene, toluene, and hot ethanol.

Originator

Burroughs Wellcome (United Kingdom)

Uses

Lamotrigine is an anticonvulsant that works by Inhibits glutamate release, possibly through inhibition of Sodium, Potassium, and Calcium currents. Used in the treatment of bipolar depression, partial seizures in epilepsy, and generalized seizures of Lennox-Gastaut syndrome. Additionally, it is used for the maintenance treatment of bipolar I disorder and depression.

Definition

ChEBI: Lamotrigine is a member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6. It has a role as an anticonvulsant, an antimanic drug, an antidepressant, a non-narcotic analgesic, a calcium channel blocker, an excitatory amino acid antagonist, an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor, an environmental contaminant, a xenobiotic and a geroprotector. It is a member of 1,2,4-triazines, a primary arylamine and a dichlorobenzene.

Preparation

The preparation method of Lamotrigine involves several steps. 2,3-dichlorobenzoic acid is chlorinated to 2,3-dichlorobenzoyl chloride, then reacted with cuprous cyanide, condensed with aminoguanidine, and finally cyclized under the action of potassium hydroxide Lamotrigine.
Two key methods for the synthesis of lamotrigine have been reported.
https://www.sciencedirect.com/topics/chemistry/lamotrigine
A novel process for the synthesis of lamotrigine and its intermediate
https://patents.google.com/patent/WO2007069265A1/en

brand name

Lamictal (Glax oSmithKline).

Therapeutic Function

Anticonvulsant

World Health Organization (WHO)

Lamotrigine is a relatively new antiepilepsy agent acting through stabilization of neuronal membranes and preventing liberation of neurotransmitters.

Biological Functions

Lamotrigine has a broad spectrum of action and is effective in generalized and partial epilepsies. Its primary mechanism of action appears to be blockage of voltagedependent sodium channels, although its effectiveness against absence seizures indicates that additional mechanisms may be active. Lamotrigine is almost completely absorbed from the gastrointestinal tract, and peak plasma levels are achieved in about 2 to 5 hours. The plasma half-life after a single dose is about 24 hours. Unlike most drugs, lamotrigine is metabolized primarily by glucuronidation. Therefore, it appears likely that lamotrigine will not induce or inhibit cytochrome P450 isozymes, in contrast to most AEDs.

General Description

Lamotrigine is an antiepileptic drug belonging in the phenyltriazine class. It is used in the treatment of both epilepsy and as a mood stabilizer in bipolar disorder. Lamotrigine is the first medication since lithium granted Food and Drug Administration (FDA) approval for the maintenance treatment of bipolar type I. It is approved for use in more than 30 countries.

Biological Activity

Anticonvulsant. Inhibits glutamate release, possibly through inhibition of Na + , K + and Ca 2+ currents.

Mechanism of action

Lamotrigine has been found effective against refractory partial seizures. Like phenytoin and CBZ, its main mechanism of action appears to be a blockade of sodium channels that is both voltage- and used-dependent. It also inhibits the high-threshold calcium channel, possibly through inhibition of presynaptic N-type calcium channels, and also blocks glutamate release. The most probable explanation for lamotrigine's efficacy is its ability to produce a blockade of sodium channel repetitive firing. In addition, lamotrigine appears to reduce glutaminergic excitatory transmission, although the mechanism for this action remains unclear.

Pharmacokinetics

Following oral administration, lamotrigine is absorbed rapidly and completely, exhibiting linear pharmacokinetics and modest protein binding (55%). Lamotrigine is metabolized predominantly by N-glucuronidation and subsequent urinary elimination of its major metabolite, the quaternary 2-N-glucuronide (80–90%), the minor 5-amino-N-glucuronide (8–10%), and unchanged drug (8–10%). Lamotrigine's usual elimination half-life of 24–35 hours is reduced to 13–15 hours in patients taking enzymeinducing AEDs. The presence of valproate increases the lamotrigine half-life substantially by inhibiting N-glucuronidation, necessitating a reduction in dose to avoid toxicity. Hepatic disease patients may demonstrate a reduced capacity to for lamotrigine glucuronidation, thus reducing its rate of clearance.

Clinical Use

Lamotrigine is a 5-phenyl-1,2,4-triazine derivative indicated as monotherapy or as an adjunct for partial seizures in adults, as adjunct in patients with Lennox-Gastaut syndrome, and as adjunct for partial seizures in children 2 years of age and older. Lamotrigine may have additional benefit in combating myoclonic and typical absence seizures. It is approved for use in the maintenance treatment of bipolar disorder.

Side effects

The usefulness of lamotrigine is limited by the increased incidence of serious rashes, particularly in children or patients taking valproate. This increase, however, may be attenuated by very slow dose escalation, because most rashes appear within the first 8 weeks of treatment. The drug should be discontinued if a rash appears at any time. Additionally, lamotrigine may be associated with development of myoclonus after 2 to 3 years of drug treatment. Additional common side effects associated with lamotrigine therapy include dizziness, diplopia, headache, ataxia, blurred vision, somnolence, and nausea.

Synthesis

The reaction of the Grignard compound of 2,3-dichloroiodobenzene with CO2 in diethyl ether gives 2,3-dichlorobenzoic acid, which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2,3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2,3-dichlorobenzoyl cyanide. Finally, this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine .

Metabolism

Lamotrigine is extensively metabolised in the liver by UDP-glucuronyl transferases and excreted almost entirely in urine, principally as an inactive glucuronide conjugate. It slightly induces its own metabolism. Only about 2% of lamotrigine-related material is excreted in faeces.

storage

Room temperature

References

https://my.clevelandclinic.org/health/drugs/20217-lamotrigine-tablets
https://pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine
https://go.drugbank.com/drugs/DB00555
The_Renal_Drug_Handbook_The_Ultimate

Lamotrigine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Lamotrigine Suppliers

Carbosynth
Tel
--
Fax
--
Email
sales@carbosynth.com
Country
United Kingdom
ProdList
6005
Advantage
58
Wessex Fine Chemicals Ltd.
Tel
--
Fax
--
Email
info@wessexfinechemicals.co.uk
Country
United Kingdom
ProdList
141
Advantage
58
R.W. Unwin & Co. Ltd
Tel
--
Fax
--
Email
sales@rwunwin.co.uk
Country
United Kingdom
ProdList
238
Advantage
58
Chirotech Technology Limited
Tel
--
Fax
--
Country
United Kingdom
ProdList
31
Advantage
58
Allchem Pharma Ingredients? (ACI Group Ltd)
Tel
--
Fax
--
Email
info@acigroup.biz
Country
United Kingdom
ProdList
147
Advantage
58
Bio-Techne Ltd. (Tocris Bioscience)
Tel
--
Fax
--
Email
info.emea@bio-techne.com
Country
United Kingdom
ProdList
120
Advantage
58
Long-Range Europe Limited
Tel
--
Fax
--
Email
info@long-range.co.uk
Country
United Kingdom
ProdList
425
Advantage
58
Molekula Limited
Tel
--
Fax
--
Email
o@molekula.com
Country
United Kingdom
ProdList
6127
Advantage
58
CMS Chemicals Limited
Tel
--
Fax
--
Email
cms.marketing@cms-chemicals.com
Country
United Kingdom
ProdList
3708
Advantage
60
Manchester Organics
Tel
--
Fax
--
Email
info@manchesterorganics.com
Country
United Kingdom
ProdList
6834
Advantage
67
Sequoia Research Products Ltd
Tel
--
Fax
--
Country
United Kingdom
ProdList
466
Advantage
58
Tocris Bioscience
Tel
--
Fax
--
Email
customerservice@tocris.co.uk
Country
United Kingdom
ProdList
5726
Advantage
77
Whyte Chemicals
Tel
--
Fax
--
Email
sales@whytechemicals.co.uk
Country
United Kingdom
ProdList
3748
Advantage
50
Leancare Ltd.
Tel
--
Fax
--
Email
enquiry@leancare.co.uk
Country
United Kingdom
ProdList
6446
Advantage
42
CARBONE SCIENTIFIC CO.,LTD
Tel
--
Fax
--
Email
sales@carbonesci.com
Country
United Kingdom
ProdList
6666
Advantage
30
KEMPROTEC Limited
Tel
--
Fax
--
Email
enquiries@kemprotec.com
Country
United Kingdom
ProdList
495
Advantage
47
Eurolabs Limited
Tel
--
Fax
--
Country
United Kingdom
ProdList
6309
Advantage
46
MOLEKULA Ltd.
Tel
--
Fax
--
Email
kevinbanks@molekula.com
Country
United Kingdom
ProdList
6140
Advantage
66
ETA SCIENTIFIC Co.,Ltd
Tel
--
Fax
--
Email
sales@etascientific.com
Country
United Kingdom
ProdList
6090
Advantage
34
UK GREEN SCIENTIFIC CO.,LIMITED
Tel
--
Fax
--
Email
sales@gs-chem.com
Country
United Kingdom
ProdList
6098
Advantage
47
Sequoia Research Products Ltd.
Tel
--
Fax
--
Email
sales@seqchem.com
Country
United Kingdom
ProdList
3113
Advantage
69
More
Less

View Lastest Price from Lamotrigine manufacturers

HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Lamotrigine 84057-84-1
Price
US $980.00-750.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000
Release date
2024-08-15
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Lamotrigine 84057-84-1
Price
US $0.00-0.00/Kg/Drum
Min. Order
1KG
Purity
98%-102%; USP
Supply Ability
1000 KGS
Release date
2021-06-17
Hebei Mojin Biotechnology Co., Ltd
Product
Lamotrigine 84057-84-1
Price
US $0.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
50000KG/month
Release date
2024-10-30

84057-84-1, LamotrigineRelated Search:


  • 4-triazine-3,5-diamine,6-(2,3-dichlorophenyl)-2
  • BW-430C
  • LAMICTAL
  • LAMOTRIGIN
  • LAMOTRIGINE
  • LAMOTRIGINE-13C1
  • GI 267119X
  • Lemotrigine
  • (2,3-Dichloro Phenyl)-1,2,4-triazine-3,5-diamine
  • 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, LTG, BW-430C, Lamictal
  • 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
  • LAMOTRINGINE
  • 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine, GI 267119X
  • 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE
  • 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE
  • LTG
  • BW-430
  • Lamotrigine 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
  • Lamotrigine (100 mg)
  • LaMotrigine API
  • LaMotrigine、3,5-DiaMino-6-(2,3- dichlorophenyl)-1,2,4-triazine
  • Lamotrigine solution
  • ORGANIC CHEMICAL, LAMOTRIGINE
  • Lamotrigine, 1000ppm
  • Lamotrigine, 98%, a novel anticonvulsant drug for inhibition of 5-HT
  • Lamotrigine for peak identification CRS
  • Lamotrigine&gt
  • Lamotrigine for system suitability CRS
  • Lamotrigine CRS
  • Lamotrigine USP/EP/BP
  • Hot selling Lamotrigine
  • Lamictal XR
  • Lamotrigine (BW430C
  • Lamotrigine, ≥98%
  • Lamotrigine 13C D3Q: What is Lamotrigine 13C D3 Q: What is the CAS Number of Lamotrigine 13C D3 Q: What is the storage condition of Lamotrigine 13C D3 Q: What are the applications of Lamotrigine 13C D3
  • Lamotrigine 13CQ: What is Lamotrigine 13C Q: What is the CAS Number of Lamotrigine 13C Q: What is the storage condition of Lamotrigine 13C Q: What are the applications of Lamotrigine 13C
  • LamotrigineQ: What is Lamotrigine Q: What is the CAS Number of Lamotrigine Q: What is the storage condition of Lamotrigine Q: What are the applications of Lamotrigine
  • Lamotrigine (1356756)
  • 2H3,13C]-Lamotrigine
  • (S)-5-(2-Aminopropyl)-2-methoxy benzenesulfonamide hydrochloride
  • LTG|||BW430C
  • Lamotrigine USP/BP/EP
  • Lamotrigine in methanol
  • 84057-84-1
  • 84507-84-1
  • 74057-84-1
  • Glutamate receptor
  • Amines
  • Heterocycles
  • Other APIs
  • VANTIN
  • Pharmaceutical intermediate
  • APIs
  • All Inhibitors
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals